Skip to content
  • Home
  • About
Search
Close

MEDCOMMSNEWS

News, Views and Opinion – Headlines from the world of the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities

Data Transparency / Publications

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

September 16, 2015September 21, 2015 Peter Llewellyn

From The BMJ.com – [Read more]

Related

Post navigation

Previous Post
Peer Review Week – A Celebration!
Next Post
No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility

Specialist news and insights from: The Publication Plan for everyone interested in medical writing, the development of medical publications, and publication planning

Research integrity across the Atlantic: our summary of the first Biomedical Transparency Summit series webinar

Research integrity: putting principles into practice

Acknowledging professional writing support in publications – are we doing enough?

Overcoming barriers to reporting negative data: perspectives from the Center for Biomedical Research Transparency’s founder

17th Annual Meeting of ISMPP: embrace new approaches & opportunities!

Archives

Index

Related service

MedComms Networking
MedComms Networking is a global initiative that facilitates networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities. Why not sign up to our weekly newsletter and please, help spread the word amongst all relevant others.
Blog at WordPress.com.
Back to top